| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.065 | 0.2 |